DAWN BLACKSHEAR: Open Payments
NPI 1467976423 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,262 in 141 payments from 45 companies in 2025. Trend: 2023 $110 · 2024 $98 · 2025 $3,262
Food & beverage: $2,771Education: $492
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $240 |
| Astellas Pharma US Inc | 7 | $233 |
| Janssen Biotech, Inc. | 15 | $196 |
| Daiichi Sankyo Inc. | 7 | $194 |
| SOBI, INC | 4 | $175 |
| Ipsen Biopharmaceuticals, Inc | 4 | $154 |
| Exelixis Inc. | 2 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $111 |
| SEAGEN INC. | 1 | $100 |
| Myriad Genetic Laboratories, Inc. | 4 | $100 |
Products named: Enhertu, KISQALI, REBLOZYL, MYRISK, ERLEADA, Xtandi, Nubeqa, RYBREVANT.
Industry payments across FL — which companies pay providers there.
